Industry: Chemical & Material
Published Date: 2026-06-16
Pages: 137 Pages
Report ld: 6760989
Request Sample
Customized Report
Pharmaceutical Excipients For Injection Market Size(US$)

CAGR 2026-2032
5.6%
Market Size,2032
USD 2,568
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pharmaceutical Excipients For Injection was estimated to be worth US$ 1763 million in 2025 and is projected to reach US$ 2568 million, growing at a CAGR of 5.6% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Excipients For Injection cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The market for pharmaceutical excipients used in injections is experiencing steady growth, fueled by ongoing innovation and expansion within the global pharmaceutical industry. The market size is continuously expanding, with increasing sales year by year. Serving as essential components of drug formulations, pharmaceutical excipients for injections play a crucial role in ensuring drug stability, enhancing efficacy, and reducing dose variability, and they find wide application across various disease treatments. With advancements in biotechnology and nanotechnology, the future of these excipients is poised to be more specialized and diverse, catering to the evolving demands of drug delivery and providing patients with safer and more effective pharmaceutical treatments.
This report provides a comprehensive view of the global market for Pharmaceutical Excipients For Injection, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Pharmaceutical Excipients For Injection market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Excipients For Injection.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Pharmaceutical Excipients For Injection manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Pharmaceutical Excipients For Injection sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Pharmaceutical Excipients For Injection sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Excipients For Injection Product Introduction
1.2 Global Pharmaceutical Excipients For Injection Market Size Forecast
1.2.1 Global Pharmaceutical Excipients For Injection Sales Value (2021–2032)
1.2.2 Global Pharmaceutical Excipients For Injection Sales Volume (2021–2032)
1.2.3 Global Pharmaceutical Excipients For Injection Sales Price (2021–2032)
1.3 Pharmaceutical Excipients For Injection Market Trends & Drivers
1.3.1 Pharmaceutical Excipients For Injection Industry Trends
1.3.2 Pharmaceutical Excipients For Injection Market Drivers & Opportunities
1.3.3 Pharmaceutical Excipients For Injection Market Challenges
1.3.4 Pharmaceutical Excipients For Injection Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Excipients For Injection Players Revenue Ranking (2025)
2.2 Global Pharmaceutical Excipients For Injection Revenue by Company (2021–2026)
2.3 Global Pharmaceutical Excipients For Injection Sales Volume Ranking of Players (2025)
2.4 Global Pharmaceutical Excipients For Injection Sales Volume by Company (2021–2026)
2.5 Global Pharmaceutical Excipients For Injection Average Price by Company (2021–2026)
2.6 Key Manufacturers Pharmaceutical Excipients For Injection Manufacturing Base and Headquarters
2.7 Key Manufacturers Pharmaceutical Excipients For Injection Product Offerings
2.8 Key Manufacturers Start of Mass Production of Pharmaceutical Excipients For Injection
2.9 Pharmaceutical Excipients For Injection Market Competitive Analysis
2.9.1 Pharmaceutical Excipients For Injection Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Excipients For Injection Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Pharmaceutical Excipients For Injection revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Pharmaceutical Excipients For Injection Market Classification
3.1 Introduction by Type
3.1.1 Solvent
3.1.2 Solubilizers
3.1.3 pH Adjuster
3.1.4 Antioxidants
3.1.5 Others
3.1.6 Global Pharmaceutical Excipients For Injection Sales Value by Type
3.1.6.1 Global Pharmaceutical Excipients For Injection Sales Value by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Pharmaceutical Excipients For Injection Sales Value, by Type (2021–2032)
3.1.6.3 Global Pharmaceutical Excipients For Injection Sales Value, by Type (%), 2021–2032
3.1.7 Global Pharmaceutical Excipients For Injection Sales Volume by Type
3.1.7.1 Global Pharmaceutical Excipients For Injection Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.7.2 Global Pharmaceutical Excipients For Injection Sales Volume, by Type (2021–2032)
3.1.7.3 Global Pharmaceutical Excipients For Injection Sales Volume, by Type (%), 2021–2032
3.1.8 Global Pharmaceutical Excipients For Injection Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Chemical Injections
4.1.2 Traditional Chinese Medicine Injections
4.1.3 Others
4.2 Global Pharmaceutical Excipients For Injection Sales Value by Application
4.2.1 Global Pharmaceutical Excipients For Injection Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Pharmaceutical Excipients For Injection Sales Value, by Application (2021–2032)
4.2.3 Global Pharmaceutical Excipients For Injection Sales Value, by Application (%), 2021–2032
4.3 Global Pharmaceutical Excipients For Injection Sales Volume by Application
4.3.1 Global Pharmaceutical Excipients For Injection Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Pharmaceutical Excipients For Injection Sales Volume, by Application (2021–2032)
4.3.3 Global Pharmaceutical Excipients For Injection Sales Volume, by Application (%), 2021–2032
4.4 Global Pharmaceutical Excipients For Injection Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Pharmaceutical Excipients For Injection Sales Value by Region
5.1.1 Global Pharmaceutical Excipients For Injection Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Pharmaceutical Excipients For Injection Sales Value by Region (2021–2026)
5.1.3 Global Pharmaceutical Excipients For Injection Sales Value by Region (2027–2032)
5.1.4 Global Pharmaceutical Excipients For Injection Sales Value by Region (%), 2021–2032
5.2 Global Pharmaceutical Excipients For Injection Sales Volume by Region
5.2.1 Global Pharmaceutical Excipients For Injection Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Pharmaceutical Excipients For Injection Sales Volume by Region (2021–2026)
5.2.3 Global Pharmaceutical Excipients For Injection Sales Volume by Region (2027–2032)
5.2.4 Global Pharmaceutical Excipients For Injection Sales Volume by Region (%), 2021–2032
5.3 Global Pharmaceutical Excipients For Injection Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Pharmaceutical Excipients For Injection Sales Value, 2021–2032
5.4.2 North America Pharmaceutical Excipients For Injection Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Pharmaceutical Excipients For Injection Sales Value, 2021–2032
5.5.2 Europe Pharmaceutical Excipients For Injection Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Excipients For Injection Sales Value, 2021–2032
5.6.2 Asia Pacific Pharmaceutical Excipients For Injection Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Pharmaceutical Excipients For Injection Sales Value, 2021–2032
5.7.2 South America Pharmaceutical Excipients For Injection Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Excipients For Injection Sales Value, 2021–2032
5.8.2 Middle East & Africa Pharmaceutical Excipients For Injection Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Excipients For Injection Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Pharmaceutical Excipients For Injection Sales Value and Sales Volume
6.2.1 Key Countries/Regions Pharmaceutical Excipients For Injection Sales Value, 2021–2032
6.2.2 Key Countries/Regions Pharmaceutical Excipients For Injection Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Pharmaceutical Excipients For Injection Sales Value, 2021–2032
6.3.2 United States Pharmaceutical Excipients For Injection Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Pharmaceutical Excipients For Injection Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Pharmaceutical Excipients For Injection Sales Value, 2021–2032
6.4.2 Europe Pharmaceutical Excipients For Injection Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Pharmaceutical Excipients For Injection Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Pharmaceutical Excipients For Injection Sales Value, 2021–2032
6.5.2 China Pharmaceutical Excipients For Injection Sales Value by Type (%), 2025 vs 2032
6.5.3 China Pharmaceutical Excipients For Injection Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Pharmaceutical Excipients For Injection Sales Value, 2021–2032
6.6.2 Japan Pharmaceutical Excipients For Injection Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Pharmaceutical Excipients For Injection Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Pharmaceutical Excipients For Injection Sales Value, 2021–2032
6.7.2 South Korea Pharmaceutical Excipients For Injection Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Pharmaceutical Excipients For Injection Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Excipients For Injection Sales Value, 2021–2032
6.8.2 Southeast Asia Pharmaceutical Excipients For Injection Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Pharmaceutical Excipients For Injection Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Pharmaceutical Excipients For Injection Sales Value, 2021–2032
6.9.2 India Pharmaceutical Excipients For Injection Sales Value by Type (%), 2025 vs 2032
6.9.3 India Pharmaceutical Excipients For Injection Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Dow
7.1.1 Dow Company Information
7.1.2 Dow Introduction and Business Overview
7.1.3 Dow Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Dow Pharmaceutical Excipients For Injection Product Offerings
7.1.5 Dow Recent Developments
7.2 Nippon Fine Chemical
7.2.1 Nippon Fine Chemical Company Information
7.2.2 Nippon Fine Chemical Introduction and Business Overview
7.2.3 Nippon Fine Chemical Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Nippon Fine Chemical Pharmaceutical Excipients For Injection Product Offerings
7.2.5 Nippon Fine Chemical Recent Developments
7.3 Nanjing Well Pharmaceutical
7.3.1 Nanjing Well Pharmaceutical Company Information
7.3.2 Nanjing Well Pharmaceutical Introduction and Business Overview
7.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Nanjing Well Pharmaceutical Pharmaceutical Excipients For Injection Product Offerings
7.3.5 Nanjing Well Pharmaceutical Recent Developments
7.4 Jiangsu Maxim Biological
7.4.1 Jiangsu Maxim Biological Company Information
7.4.2 Jiangsu Maxim Biological Introduction and Business Overview
7.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Jiangsu Maxim Biological Pharmaceutical Excipients For Injection Product Offerings
7.4.5 Jiangsu Maxim Biological Recent Developments
7.5 NOF
7.5.1 NOF Company Information
7.5.2 NOF Introduction and Business Overview
7.5.3 NOF Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 NOF Pharmaceutical Excipients For Injection Product Offerings
7.5.5 NOF Recent Developments
7.6 Croda
7.6.1 Croda Company Information
7.6.2 Croda Introduction and Business Overview
7.6.3 Croda Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Croda Pharmaceutical Excipients For Injection Product Offerings
7.6.5 Croda Recent Developments
7.7 Jiangsu Poly Pharmaceutical
7.7.1 Jiangsu Poly Pharmaceutical Company Information
7.7.2 Jiangsu Poly Pharmaceutical Introduction and Business Overview
7.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients For Injection Product Offerings
7.7.5 Jiangsu Poly Pharmaceutical Recent Developments
7.8 Er Kang Pharmaceutical
7.8.1 Er Kang Pharmaceutical Company Information
7.8.2 Er Kang Pharmaceutical Introduction and Business Overview
7.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Er Kang Pharmaceutical Pharmaceutical Excipients For Injection Product Offerings
7.8.5 Er Kang Pharmaceutical Recent Developments
7.9 Guangzhou Hanfang Pharmaceutical
7.9.1 Guangzhou Hanfang Pharmaceutical Company Information
7.9.2 Guangzhou Hanfang Pharmaceutical Introduction and Business Overview
7.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients For Injection Product Offerings
7.9.5 Guangzhou Hanfang Pharmaceutical Recent Developments
7.10 Pfanstiehl
7.10.1 Pfanstiehl Company Information
7.10.2 Pfanstiehl Introduction and Business Overview
7.10.3 Pfanstiehl Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Pfanstiehl Pharmaceutical Excipients For Injection Product Offerings
7.10.5 Pfanstiehl Recent Developments
7.11 Xi'an Libang Pharmaceutical
7.11.1 Xi'an Libang Pharmaceutical Company Information
7.11.2 Xi'an Libang Pharmaceutical Introduction and Business Overview
7.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Xi'an Libang Pharmaceutical Pharmaceutical Excipients For Injection Product Offerings
7.11.5 Xi'an Libang Pharmaceutical Recent Developments
7.12 Zhejiang Tianyushan Medicinal Oil
7.12.1 Zhejiang Tianyushan Medicinal Oil Company Information
7.12.2 Zhejiang Tianyushan Medicinal Oil Introduction and Business Overview
7.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients For Injection Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients For Injection Product Offerings
7.12.5 Zhejiang Tianyushan Medicinal Oil Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical Excipients For Injection Industrial Chain
8.2 Pharmaceutical Excipients For Injection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Pharmaceutical Excipients For Injection Sales Model
8.5.2 Sales Channels
8.5.3 Pharmaceutical Excipients For Injection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Excipients For Injection market was valued at US$ 1763 million in 2025 and is anticipated to reach US$ 2568 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 136
USD 2900.00
(Single User License)
The global Pharmaceutical Excipients For Injection market size was US$ 1679 million in 2024 and is forecast to a readjusted size of US$ 2445 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 94
USD 4250.00
(Single User License)
The global Pharmaceutical Excipients For Injection market is projected to grow from US$ 1679 million in 2024 to US$ 2445 million by 2031, at a CAGR of 5.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 166
USD 4900.00
(Single User License)
The global market for Pharmaceutical Excipients For Injection was valued at US$ 1679 million in the year 2024 and is projected to reach a revised size of US$ 2445 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published Date: 2025-01-16
Pages: 104
USD 2900.00
(Single User License)
The global market for Pharmaceutical Excipients For Injection was estimated to be worth US$ 1679 million in 2024 and is forecast to a readjusted size of US$ 2445 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 123
USD 3950.00
(Single User License)
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published Date: 2024-04-12
Pages: 106
USD 4900.00
(Single User License)
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published Date: 2024-01-17
Pages: 103
USD 2900.00
(Single User License)
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published Date: 2024-01-10
Pages: 124
USD 3950.00
(Single User License)
The global Pharmaceutical Excipients For Injection market was valued at US$ 1763 million in 2025 and is anticipated to reach US$ 2568 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-04-18
Pages: 136
The global Pharmaceutical Excipients For Injection market size was US$ 1679 million in 2024 and is forecast to a readjusted size of US$ 2445 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 94
The global Pharmaceutical Excipients For Injection market is projected to grow from US$ 1679 million in 2024 to US$ 2445 million by 2031, at a CAGR of 5.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 166
The global market for Pharmaceutical Excipients For Injection was valued at US$ 1679 million in the year 2024 and is projected to reach a revised size of US$ 2445 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published: 2025-01-16
Pages: 104
The global market for Pharmaceutical Excipients For Injection was estimated to be worth US$ 1679 million in 2024 and is forecast to a readjusted size of US$ 2445 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 123
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published: 2024-04-12
Pages: 106
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published: 2024-01-17
Pages: 103
Excipients for injection refer to the general term for other ingredients other than active ingredients in sterile preparations such as injections, implants, and wound washes. Compared with other non-injectable pharmaceutical excipients, injectable pharmaceutical excipients have higher requirements on safety, quality, manufacturing equipment and packaging because they directly enter the human blood circulation through injection.
Published: 2024-01-10
Pages: 124
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now